Raviraj Kulathila

Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers

Julien P. N. Papillon, Katsumasa Nakajima, Christopher D. Adair et al. · Journal of Medicinal Chemistry · 2018 · 237 citations · Full text

Medicine, Cancer Biology, Oncology +11

Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor

Young Shin Cho, Julian Levell, Gang Liu et al. · ACS Medicinal Chemistry Letters · 2017 · 118 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

<i>N</i>-Alkyl Urea Hydroxamic Acids as a New Class of Peptide Deformylase Inhibitors with Antibacterial Activity

C J Hackbarth, Dawn Z. Chen, Jason G. Lewis et al. · Antimicrobial Agents and Chemotherapy · 2002 · 108 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Structural Investigations on the Coordination Environment of the Active-Site Copper Centers of Recombinant Bifunctional Peptidylglycine α-Amidating Enzyme

John S. Boswell, Brian Reedy, Raviraj Kulathila et al. · Biochemistry · 1996 · 90 citations

Life Sciences, Biochemistry, Chemistry +17

The Role of the Acidity of N-Heteroaryl Sulfonamides as Inhibitors of Bcl-2 Family Protein–Protein Interactions

B. Barry Touré, Karen Miller‐Moslin, Naeem Yusuff et al. · ACS Medicinal Chemistry Letters · 2013 · 77 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16